In the last 12 months, insiders at Estrella Immunopharma, Inc. ($ESLA) filed 4 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
Estrella Immunopharma, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Liu Cheng (Chief Executive Officer) — 2 transactions totaling $0
- Xu Jiandong (Chief Financial Officer) — 2 transactions totaling $0
View all SEC Filings for Estrella Immunopharma, Inc. (ESLA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 30, 2024 | Liu Cheng | Chief Executive Officer | A | Incentive Share Option | 490796 | $0.00 | 490,796.0000 | 36,208,477 | 9999.99% | 1.36% |
| Oct. 30, 2024 | Liu Cheng | Chief Executive Officer | A | Nonstatutory Share Option | 509204 | $0.00 | 509,203.0000 | 36,208,477 | 0.00% | 1.41% |
| Oct. 30, 2024 | Xu Jiandong | Chief Financial Officer | A | Incentive Share Option | 490796 | $0.00 | 490,796.0000 | 36,208,477 | 9999.99% | 1.36% |
| Oct. 30, 2024 | Xu Jiandong | Chief Financial Officer | A | Nonstatutory Share Option | 509204 | $0.00 | 509,203.0000 | 36,208,477 | 0.00% | 1.41% |